1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEWAMSTERDAM PHARMA COMPANY NV
NewAmsterdam Pharma Company NV
XNAS: NAMS
Download real time
28.42 -0.01 (-0.04%)
32.33% Fall from 52W High
192.5K
XNAS Volume

XNAS 30 Apr, 2026 1:29 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for NewAmsterdam Pharma Co NV is on 08 May 2026 for the purpose of NewAmsterdam Pharma Co NV First Quarter Earnings Results for 2026 See details

NewAmsterdam Pharma Co NV - NAMS - stock price prediction, stock price target, analyst ratings from 15 analysts

NewAmsterdam Pharma Co NV has a share price target of US$ 50, revenue growth forecast of 13.7%, and profit growth estimate of -17.4% for FY26, based on top 15 analyst calls.

Forecaster Screeners